BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $13.89 million. The enterprise value is $104,195.

Market Cap	13.89M
Enterprise Value	104,195

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

BiomX has 18.18 million shares outstanding. The number of shares has increased by 105.68% in one year.

Current Share Class	18.18M
Shares Outstanding	18.18M
Shares Change (YoY)	+105.68%
Shares Change (QoQ)	+8.99%
Owned by Insiders (%)	3.70%
Owned by Institutions (%)	30.59%
Float	9.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.72
P/TBV Ratio	3.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.17, with a Debt / Equity ratio of 0.26.

Current Ratio	3.17
Quick Ratio	2.75
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.97

Financial Efficiency

Return on equity (ROE) is -37.81% and return on invested capital (ROIC) is -56.09%.

Return on Equity (ROE)	-37.81%
Return on Assets (ROA)	-43.41%
Return on Capital (ROIC)	-56.09%
Revenue Per Employee	n/a
Profits Per Employee	-$122,606
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $11,000 in taxes.

Income Tax	11,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.68% in the last 52 weeks. The beta is 1.26, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	-64.68%
50-Day Moving Average	0.67
200-Day Moving Average	1.96
Relative Strength Index (RSI)	56.35
Average Volume (20 Days)	110,976

Short Selling Information

The latest short interest is 23,032, so 0.13% of the outstanding shares have been sold short.

Short Interest	23,032
Short Previous Month	37,156
Short % of Shares Out	0.13%
Short % of Float	0.23%
Short Ratio (days to cover)	0.74

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-32.31M
Pretax Income	-37.11M
Net Income	-8.71M
EBITDA	-31.22M
EBIT	-32.31M
Earnings Per Share (EPS)	-$3.69

Full Income Statement

Balance Sheet

The company has $23.54 million in cash and $9.75 million in debt, giving a net cash position of $13.79 million or $0.76 per share.

Cash & Cash Equivalents	23.54M
Total Debt	9.75M
Net Cash	13.79M
Net Cash Per Share	$0.76
Equity (Book Value)	37.90M
Book Value Per Share	1.06
Working Capital	19.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.93 million and capital expenditures -$26,000, giving a free cash flow of -$36.96 million.

Operating Cash Flow	-36.93M
Capital Expenditures	-26,000
Free Cash Flow	-36.96M
FCF Per Share	-$2.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-105.68%
Shareholder Yield	-105.68%
Earnings Yield	-62.65%
FCF Yield	-266.00%

Analyst Forecast

The average price target for BiomX is $13.50, which is 1,667.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.50
Price Target Difference	1,667.02%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-6.31%

Stock Forecasts

Stock Splits

The last stock split was on August 26, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Aug 26, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1